Our patient was vigorously scrutinized for metastatic disease, which included routine blood chemistries and the determination of lipid associated sialic acid, carcinoembryonic antigen (CEA) and CA 15-3 serum markers. The gene discussed is CEACAM5; the disease is metastatic neoplasm.